Israel Active

As reported previously, Aviptadil from Israel’s NeuroRx, is undergoing Phase 2/3 trials in Israel and the US. The adapted treatment, now known as RLF-100, prevents Covid-19 replication and has already significantly improved the health of 15 emergency cases in the US.

A bullet from Muslim holiday Eid al-Adha celebrations hit a 9-year-old Arab boy in the head. At Jerusalem’s Hadassah Medical Center, Israeli neurosurgeons removed the bullet from deep inside the boy’s brain. Two days after the surgery, the boy was eating, talking and moving his limbs.

This video shows up-to-date information on the research work being conducted at the Hebrew University of Jerusalem into testing and treatments for Covid-19.

This video shows Technion scientists working on to improve Covid-19 testing, screen for contagion, fast track vaccines, , , , , , and more.

Israel's Minister of Defense Benny Gantz has announced that the Israel Institute of Biological Research will begin human trials of its Covid-19 vaccine in October. Phase 1 clinical trials for safety and efficacy will begin after the Jewish holidays that end on Oct 9th.

74-year old Marina Chivatova was discharged from Jerusalem’s Shaare Zedek Medical Center after having spent no less than 99 days in the hospital’s Corona Unit.  It could be the world’s longest stay for a hospitalized Covid-19 patient and shows that Israel never gives up.

Scientists at Israel’s Weizmann Institute and at MIT and Harvard can identify the most suitable cancer therapy from the signals detected in the tumor itself. They analyze the pathway of the tumor using PathOlogist - an advanced bioinformatics tool developed by Bar-Ilan professor Sol Efroni.

More on the nano-engineered pomegranate oil antioxidant produced by scientists at Jerusalem’s Hadassah hospital. It is now being targeted at sufferers of Creutzfeldt-Jakob Disease (CJD) - common in specific Jewish groups.  The latest findings give hope.

In her lab, Professor Illana Gozes of Tel Aviv University (reported previously) repaired live but damaged brain cells taken from deceased Alzheimer’s patients and an autistic child. It showed that her experimental NAP peptide could be used to treat both conditions.

Another excellent medical webinar from Techion UK. Sleep And Dreams featured Professor Peretz Lavie, former President of Israel’s Technion Institute. He explained some of the mysteries about sleep and dreams.